Eli Lilly’s Zepbound drug holds potential to dominate the global obesity market due to its superior efficacy and strategic ...

Our vision is to innovate and incorporate promising technologies to communicate freely available, high-priority, high-quality content, which accelerates scientific progress and advances heart and ...

The obesity rate among U.S. adults fell in 2023 for the first time in over a decade, according to a new study released on Friday. The study published in the journal JAMA Health Forum found that ...

Although fast foods are high in calories, they are not nutritious. So, the frequent intake or consumption of fast food is associated with many health problems, such as obesity, type 2 diabetes, and ...

Terri-Lynne South is a GP and dietitian specialising in obesity.(Supplied: Dean Canton) She says fat-shaming and weight stigma is "extremely prevalent" in medical settings. "It's not helpful ...

Eli Lilly, the company that makes the blockbuster weight loss treatment Zepbound, will start studying its obesity products as treatments for alcohol and drug addiction, making it the first major ...

This “upstream parable” illustrates the folly of America’s response to obesity. Like the villagers, Americans have relied on reactive, downstream solutions to combat the problem. Bariatric ...

For decades, researchers from all obesity-related disciplines have been observing the escalating prevalence of people living with overweight and obesity worldwide. Researchers always follow and ...

These are the key findings of our recent study, published in the journal The Lancet ... we based definitions on the International Obesity Task Force criteria. This study was conducted by the ...

Anti-obesity medications are often used to help people who have tried and not been able to lose enough weight through exercise and dietary changes. Obesity is a widespread issue affecting over 40% ...

environmental factors and the activation of immune responses -- ultimately driven by obesity and metabolic syndrome," Schaeffer said in a journal news release. Midway through the study ...